Seeing Is Believing
Currently out of the existing stock ratings of Robert Burns, 250 are a BUY (91.58%), 23 are a HOLD (8.42%).
Analyst Robert Burns works with a stock forecast success ratio of 22.93% fulfilled within 81.21 days on average. Previously, Robert Burns worked at HCWAINWRIGHT.
Robert Burns’s has documented 537 price targets and ratings displayed on 38 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYME, Zymeworks . Common Stock at 07-May-2024.
Analyst best performing recommendations are on ZYME (ZYMEWORKS . COMMON STOCK).
The best stock recommendation documented was for ADCT (ADC THERAPEUTICS SA) at 11/20/2023. The price target of $3 was fulfilled within 70 days with a profit of $2.29 (322.54%) receiving and performance score of 46.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$2.89 (136.97%)
30
4 months 23 days ago
0/5 (0%)
$2.66 (113.68%)
Hold
4 months 23 days ago
0/4 (0%)
$31.56 (191.97%)
Buy
4 months 23 days ago
0/1 (0%)
$20.97 (87.27%)
Buy
2 years 27 days ago
0/1 (0%)
$93 (163.16%)
Buy
2 years 27 days ago
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Robert Burns is most bullish on?
Which stock is Robert Burns is most reserved on?
What Year was the first public recommendation made by Robert Burns?